BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 4037759)

  • 1. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy.
    Arnold DL; Taylor DJ; Radda GK
    Ann Neurol; 1985 Aug; 18(2):189-96. PubMed ID: 4037759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders.
    Argov Z; Bank WJ
    Ann Neurol; 1991 Jul; 30(1):90-7. PubMed ID: 1834009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for mitochondrial dysfunction in patients with alternating hemiplegia of childhood.
    Arnold DL; Silver K; Andermann F
    Ann Neurol; 1993 Jun; 33(6):604-7. PubMed ID: 8498840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study.
    Taylor DJ; Bore PJ; Styles P; Gadian DG; Radda GK
    Mol Biol Med; 1983 Jul; 1(1):77-94. PubMed ID: 6679873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced mitochondrial adenosine triphosphate synthesis in skeletal muscle in patients with Child-Pugh class B and C cirrhosis.
    Jacobsen EB; Hamberg O; Quistorff B; Ott P
    Hepatology; 2001 Jul; 34(1):7-12. PubMed ID: 11431727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo magnetic resonance spectroscopy of brain and muscle in a type of mitochondrial encephalomyopathy (MERRF).
    Matthews PM; Berkovic SF; Shoubridge EA; Andermann F; Karpati G; Carpenter S; Arnold DL
    Ann Neurol; 1991 Apr; 29(4):435-8. PubMed ID: 1929212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle.
    Pipinos II; Shepard AD; Anagnostopoulos PV; Katsamouris A; Boska MD
    J Vasc Surg; 2000 May; 31(5):944-52. PubMed ID: 10805885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine.
    Eleff SM; Barker PB; Blackband SJ; Chatham JC; Lutz NW; Johns DR; Bryan RN
    Ann Neurol; 1990 Jun; 27(6):626-30. PubMed ID: 2360799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Muscular energetics studied by nuclear magnetic resonance spectroscopy of phosphorus (cardiac and skeletal muscles)].
    Rossi A
    Arch Int Physiol Biochim; 1988 Sep; 96(4):A393-409. PubMed ID: 2463818
    [No Abstract]   [Full Text] [Related]  

  • 10. Impaired resting muscle energetics studied by (31)P-NMR in diet-induced obese rats.
    Chanseaume E; Bielicki G; Tardy AL; Renou JP; Freyssenet D; Boirie Y; Morio B
    Obesity (Silver Spring); 2008 Mar; 16(3):572-7. PubMed ID: 18239558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo skeletal muscle metabolism during dynamic exercise and recovery: assessment by nuclear magnetic resonance spectroscopy.
    Wong R; Lopaschuk G; Teo K; Walker D; Catellier D; Zhu G; Burton D; Collins-Nakai R; Montague T
    Can J Cardiol; 1992 Oct; 8(8):819-24. PubMed ID: 1423003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of dynamic ³¹P magnetic resonance spectroscopy technique in in vivo assessment of the skeletal muscle mitochondrial function in type 2 diabetes.
    Wu FY; Tu HJ; Qin B; Chen T; Xu HF; Qi J; Wang DH
    Chin Med J (Engl); 2012 Jan; 125(2):281-6. PubMed ID: 22340560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic abnormalities in skeletal muscle of patients receiving zidovudine therapy observed by 31P in vivo magnetic resonance spectroscopy.
    Sinnwell TM; Sivakumar K; Soueidan S; Jay C; Frank JA; McLaughlin AC; Dalakas MC
    J Clin Invest; 1995 Jul; 96(1):126-31. PubMed ID: 7615782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease.
    Matthews PM; Allaire C; Shoubridge EA; Karpati G; Carpenter S; Arnold DL
    Neurology; 1991 Jan; 41(1):114-20. PubMed ID: 1985275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic uraemia on skeletal muscle metabolism in man.
    Thompson CH; Kemp GJ; Taylor DJ; Ledingham JG; Radda GK; Rajagopalan B
    Nephrol Dial Transplant; 1993; 8(3):218-22. PubMed ID: 8385287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis alters skeletal muscle energetics and membrane function.
    Jacobs DO; Kobayashi T; Imagire J; Grant C; Kesselly B; Wilmore DW
    Surgery; 1991 Aug; 110(2):318-25; 325-6. PubMed ID: 1650038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADP recovery after a brief ischemic exercise in normal and diseased human muscle--a 31P MRS study.
    Argov Z; De Stefano N; Arnold DL
    NMR Biomed; 1996 Jun; 9(4):165-72. PubMed ID: 9015803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uraemic muscle metabolism at rest and during exercise.
    Thompson CH; Kemp GJ; Barnes PR; Rajagopalan B; Styles P; Taylor DJ; Radda GK
    Nephrol Dial Transplant; 1994; 9(11):1600-5. PubMed ID: 7870350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphocreatine synthesis by isolated rat skeletal muscle mitochondria is not dependent upon external ADP: a 31P NMR study.
    Kernec F; Le Tallec N; Nadal L; Bégué JM; Le Rumeur E
    Biochem Biophys Res Commun; 1996 Aug; 225(3):819-25. PubMed ID: 8780696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-31 magnetic resonance spectroscopy of skeletal muscle in the eosinophilia-myalgia syndrome: a preliminary study.
    Clauw DJ; Hewes B; Nelson M; Katz P; Rajan S
    J Rheumatol; 1994 Apr; 21(4):654-7. PubMed ID: 8035389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.